Integra LifeSciences Holdings EBITDA Margin 2010-2023 | IART
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Integra LifeSciences Holdings (IART) over the last 10 years. The current EBITDA margin for Integra LifeSciences Holdings as of December 31, 2023 is .
| Integra LifeSciences Holdings EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2023-12-31 | $1.54B | $0.24B | 15.64% |
| 2023-09-30 | $1.54B | $0.27B | 17.64% |
| 2023-06-30 | $1.55B | $0.31B | 20.00% |
| 2023-03-31 | $1.56B | $0.36B | 22.73% |
| 2022-12-31 | $1.56B | $0.36B | 23.36% |
| 2022-09-30 | $1.57B | $0.36B | 22.73% |
| 2022-06-30 | $1.57B | $0.35B | 22.19% |
| 2022-03-31 | $1.56B | $0.34B | 21.79% |
| 2021-12-31 | $1.54B | $0.32B | 21.00% |
| 2021-09-30 | $1.53B | $0.32B | 20.84% |
| 2021-06-30 | $1.51B | $0.33B | 21.74% |
| 2021-03-31 | $1.38B | $0.29B | 21.34% |
| 2020-12-31 | $1.37B | $0.30B | 21.50% |
| 2020-09-30 | $1.38B | $0.28B | 19.96% |
| 2020-06-30 | $1.39B | $0.19B | 13.34% |
| 2020-03-31 | $1.51B | $0.21B | 13.89% |
| 2019-12-31 | $1.52B | $0.21B | 13.70% |
| 2019-09-30 | $1.51B | $0.21B | 13.68% |
| 2019-06-30 | $1.49B | $0.25B | 16.88% |
| 2019-03-31 | $1.48B | $0.24B | 15.93% |
| 2018-12-31 | $1.47B | $0.23B | 15.49% |
| 2018-09-30 | $1.46B | $0.20B | 13.72% |
| 2018-06-30 | $1.37B | $0.18B | 12.98% |
| 2018-03-31 | $1.29B | $0.16B | 12.43% |
| 2017-12-31 | $1.19B | $0.14B | 11.44% |
| 2017-09-30 | $1.08B | $0.16B | 14.96% |
| 2017-06-30 | $1.05B | $0.18B | 17.00% |
| 2017-03-31 | $1.01B | $0.18B | 17.75% |
| 2016-12-31 | $0.99B | $0.19B | 19.25% |
| 2016-09-30 | $0.98B | $0.17B | 17.81% |
| 2016-06-30 | $0.95B | $0.15B | 15.95% |
| 2016-03-31 | $0.92B | $0.15B | 16.14% |
| 2015-12-31 | $0.88B | $0.14B | 15.97% |
| 2015-09-30 | $0.80B | $0.14B | 17.74% |
| 2015-06-30 | $0.77B | $0.14B | 17.86% |
| 2015-03-31 | $0.79B | $0.13B | 16.31% |
| 2014-12-31 | $0.80B | $0.12B | 14.68% |
| 2014-09-30 | $0.73B | $0.13B | 18.34% |
| 2014-06-30 | $0.74B | $0.09B | 12.30% |
| 2014-03-31 | $0.72B | $0.08B | 11.47% |
| 2013-12-31 | $0.70B | $0.07B | 9.90% |
| 2013-09-30 | $0.83B | $0.04B | 5.18% |
| 2013-06-30 | $0.83B | $0.10B | 11.61% |
| 2013-03-31 | $0.83B | $0.11B | 13.12% |
| 2012-12-31 | $0.83B | $0.13B | 15.66% |
| 2012-09-30 | $0.82B | $0.12B | 14.39% |
| 2012-06-30 | $0.81B | $0.12B | 14.29% |
| 2012-03-31 | $0.80B | $0.11B | 13.58% |
| 2011-12-31 | $0.78B | $0.11B | 13.85% |
| 2011-09-30 | $0.77B | $0.12B | 15.84% |
| 2011-06-30 | $0.76B | $0.13B | 16.82% |
| 2011-03-31 | $0.74B | $0.14B | 18.49% |
| 2010-12-31 | $0.73B | $0.14B | 18.83% |
| 2010-09-30 | $0.72B | $0.14B | 19.92% |
| 2010-06-30 | $0.71B | $0.14B | 19.92% |
| 2010-03-31 | $0.70B | $0.14B | 20.14% |
| 2009-12-31 | $0.68B | $0.14B | 20.50% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $2.501B | $1.542B |
| Integra LifeSciences is one of the world leaders in regenerative medicine. The company develops, manufactures and markets cost-effective surgical implants and medical instruments. The company now manufactures and sells products in the following two global reportable business segments: Codman Specialty Surgical (CSS) and Orthopedics and Tissue Technologies (OTT). The CSS business offers global, market-leading technologies, brands and instrumentation. The global commercial network includes clinical specialists, a large direct global sales force and strategic partnerships and distributors that serve hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers and health care providers in North America, South America, Europe, Asia Pacific, Middle East and Africa. The Tissue Technologies segment includes wound reconstruction and repair products, bone grafts and nerve and tendon repair products. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $211.679B | 25.75 |
| Intuitive Surgical (ISRG) | United States | $134.177B | 83.75 |
| Edwards Lifesciences (EW) | United States | $54.204B | 35.88 |
| DexCom (DXCM) | United States | $52.631B | 90.41 |
| IQVIA Holdings (IQV) | United States | $41.589B | 24.67 |
| IDEXX Laboratories (IDXX) | United States | $40.661B | 48.62 |
| Alcon (ALC) | Switzerland | $39.256B | 28.95 |
| STERIS (STE) | Ireland | $19.665B | 23.28 |
| Waters (WAT) | United States | $18.607B | 26.70 |
| Hologic (HOLX) | United States | $17.631B | 19.46 |
| SONOVA HOLDING (SONVY) | Switzerland | $16.535B | 0.00 |
| ShockWave Medical (SWAV) | United States | $12.247B | 84.62 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $10.915B | 13.48 |
| Sysmex ADR (SSMXY) | Japan | $9.988B | 31.32 |
| Teleflex (TFX) | United States | $9.896B | 15.54 |
| Penumbra (PEN) | United States | $8.130B | 100.50 |
| Masimo (MASI) | United States | $7.312B | 41.00 |
| Globus Medical (GMED) | United States | $7.011B | 22.23 |
| Glaukos (GKOS) | United States | $4.796B | 0.00 |
| Integer Holdings (ITGR) | United States | $3.997B | 25.55 |
| TransMedics (TMDX) | United States | $3.052B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.869B | 18.92 |
| Elekta AB (EKTAY) | Sweden | $2.673B | 18.34 |
| PROCEPT BioRobotics (PRCT) | United States | $2.650B | 0.00 |
| Nihon Kohden (NHNKY) | Japan | $2.368B | 20.03 |
| Inari Medical (NARI) | United States | $2.266B | 391.00 |
| Tandem Diabetes Care (TNDM) | United States | $2.128B | 0.00 |
| RxSight (RXST) | United States | $2.009B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $1.820B | 0.00 |
| Veracyte (VCYT) | United States | $1.420B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.862B | 15.94 |
| OPKO Health (OPK) | United States | $0.843B | 0.00 |
| Artivion (AORT) | United States | $0.837B | 96.71 |
| Paragon 28 (FNA) | United States | $0.799B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.718B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.712B | 0.00 |
| Silk Road Medical (SILK) | United States | $0.694B | 0.00 |
| SiBone (SIBN) | United States | $0.630B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.553B | 18.77 |
| IRadimed (IRMD) | United States | $0.520B | 30.17 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.493B | 0.00 |
| Nevro (NVRO) | United States | $0.466B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $0.430B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.375B | 0.00 |
| NeuroPace (NPCE) | United States | $0.369B | 0.00 |
| CVRx (CVRX) | United States | $0.354B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.342B | 11.50 |
| AxoGen (AXGN) | United States | $0.306B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.271B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.261B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.259B | 0.00 |
| Accuray (ARAY) | United States | $0.221B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.193B | 0.00 |
| 908 Devices (MASS) | United States | $0.191B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.190B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.183B | 9.84 |
| Inogen (INGN) | United States | $0.162B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.151B | 0.00 |
| Neuronetics (STIM) | United States | $0.121B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.120B | 0.00 |
| Envoy Medical (COCH) | United States | $0.117B | 0.00 |
| Yubo Biotech (YBGJ) | China | $0.112B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.098B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.090B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.083B | 0.00 |
| Hyperfine (HYPR) | United States | $0.071B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.063B | 0.00 |
| SEP Acquisition (SEPA) | United States | $0.058B | 0.00 |
| Vasomedical (VASO) | United States | $0.057B | 10.32 |
| InspireMD (NSPR) | Israel | $0.053B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.052B | 106.67 |
| Autonomix Medical (AMIX) | United States | $0.052B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.052B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.043B | 0.00 |
| ReWalk Robotics (LFWD) | Israel | $0.042B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.040B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.039B | 0.00 |
| Pixie Dust Technologies (PXDT) | Japan | $0.038B | 0.00 |
| Spectral AI (MDAI) | United States | $0.035B | 0.00 |
| DarioHealth (DRIO) | United States | $0.034B | 0.00 |
| LENSAR (LNSR) | United States | $0.034B | 0.00 |
| Precision Optics (POCI) | United States | $0.033B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.024B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.024B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.018B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.018B | 0.00 |
| PAVmed (PAVM) | United States | $0.017B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.017B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.014B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.014B | 0.00 |
| NexGel (NXGL) | United States | $0.013B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.013B | 0.00 |
| Avinger (AVGR) | United States | $0.006B | 0.00 |
| Venus Concept (VERO) | Canada | $0.005B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.005B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Tenon Medical (TNON) | United States | $0.003B | 0.00 |
| Dynatronics (DYNT) | United States | $0.003B | 0.00 |
| Nuwellis (NUWE) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.001B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.001B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |